中财网 中财网股票行情
恩威医药(301331)财务分析指标    年份：
截止日期2025-03-312024-12-312024-09-302024-06-302024-03-31
营业总收入(万元)19649.9581212.7456034.1138814.9518347.59
营业收入(万元)19649.9581212.7456034.1138814.9518347.59
营业总成本(万元)18373.3776317.2553660.7336846.9817411.71
营业成本(万元)10192.8939944.3927483.6918679.769126.00
净利润(万元)1630.513749.752202.201793.44842.39
归属于母公司的净利润(万元)1630.513749.752202.201793.44842.39
营业利润(万元)1819.594968.652853.332334.911049.26
利润总额(万元)1798.664668.382552.262293.791049.20
少数股东损益(万元)----------
基本每股收益(元)0.16(元)0.37(元)0.22(元)0.18(元)0.08(元)
稀释每股收益(元)0.16(元)0.37(元)0.22(元)0.18(元)0.08(元)
非经常性损益(万元)168.03276.79157.89276.00--
扣除非经常性损益后净利润(万元)1462.483472.962044.301517.45668.02
总资产(万元)149627.01150452.89142289.46147132.59135553.74
总负债(万元)41976.5244685.7840093.0445776.5327598.54
归属于母公司股东权益合计(万元)107650.50105767.11102196.41101356.06107955.20
股东权益合计(万元)107650.50105767.11102196.41101356.06107955.20
实收资本(股本)(万元)10289.1910289.1910289.1910289.197013.84
资本公积(万元)64123.9763871.1066105.6665454.0967940.13
未分配利润(万元)35464.0933833.5832470.0332061.2836567.70
经营活动产生的现金流量净额(万元)2467.817891.977146.459027.10606.69
经营活动现金流入小计(万元)19990.1874968.8356708.5042327.0017125.28
经营活动现金流出小计(万元)17522.3767076.8649562.0533299.9016518.59
投资活动产生的现金流量净额(万元)-1997.44-11061.74-1348.463078.54-1305.22
投资活动现金流入小计(万元)42247.9395771.7664060.3544244.9321836.22
投资活动现金流出小计(万元)44245.37106833.4965408.8141166.3923141.44
筹资活动产生的现金流量净额(万元)-82.888510.467163.229653.96-814.44
筹资活动现金流入小计(万元)--26016.3624180.0024180.003300.00
筹资活动现金流出小计(万元)82.8817505.9017016.7814526.044114.44
期末现金及现金等价物余额(万元)29309.8828922.3836542.8945341.2822068.71
最后修改日期2025-04-212025-04-212024-10-242024-08-302025-04-21
↑返回页顶↑

转至恩威医药（301331）行情首页

中财网免费提供股票、基金、债券、外汇、理财等行情数据以及其他资料，仅供用户获取信息。